Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NEP inhibitors claimed by Santen

Nov. 28, 1996

XOMA receives U.S. patents covering BPI-related products

Nov. 27, 1996

Japanese researchers describe orally active antihypertensive agents

Nov. 27, 1996

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

HMG-CoA reductase inhibitors for preventing second heart attack

Nov. 26, 1996

New market introduction for valsartan

Nov. 26, 1996

Cozaar introduced in U.K.

Nov. 26, 1996

New antihypertensive agent from Calpis Food Industry

Nov. 26, 1996

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Nov. 22, 1996

Calcium channel blocker update

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...